DePuy Hip Implant's Failure Rate 'Striking,' Jury Told

Law360, Los Angeles (January 28, 2013, 9:32 PM EST) -- DePuy Inc.'s metal ASR XL hip implants failed at five times the rate of other types of hip implants, a medical expert told a California jury Monday during a bellwether trial against the Johnson & Johnson subsidiary, the first of thousands nationwide to go to trial.

Dr. John A. Baron, a professor at the Geisel School of Medicine at Dartmouth College, testified that 22 percent of DePuy's ASR XL metal-on-metal hip implant needed replacement within five years. Baron said he based his opinion on hip implant...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.